2018年度業績集

原著

  1. Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease.Takedatsu, H., Mitsuyama, K.,Fukunaga, S., Yoshioka, S, Yamauchi, R, Mori, A., Yamasaki, H., Kuwaki, K., Sakisaka, H., Sakisaka, S., Torimura, T. J Gastroenterol Hepatol.　33:1603-1607,2018
  2. Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection.Ko YL, Morihara D, Shibata K, Yamauchi R, Fukuda H, Kunimoto H, Takata K, Tanaka T, Inomata S, Yokoyama K, Takeyama Y, Shakado S, Sakisaka S.Nutrients.　 2;10(11). pii: E1620. ,2018
  3. Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis.Yokoyama K, Yamauchi R, Shibata K, Fukuda H, Kunimoto H, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S.Clin Mol Hepatol.　doi: 10.3350/cmh.2018.0039. [Epub ahead of print]
  4. POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.SCIENTIFIC REPORTS　14;9(1):102.,2019
  5. Analysis of 307 cases with drug-induced liver injury between2010 and 2018 in JapanAiso M, Takikawa H,Tsuji K,Kagawa T,Watanabe M,Tanaka , Sato K,Sakisaka S , Hiasa Y, Takei Y, Ohira H, Ayada M,Hashimoto E,Kaneko S, Ueno Y ,Ohmoto K,Takaki A,Torimura T,Matsuzaki Y,Tajiri K,Yoneda M, Ito T,Kato N,Ikejima K,Mochida S, Yasuda H, Sakamoto NHepatology Research　49：105-110, 2019
  6. Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel.Hiraishi K, Kurahara LH, Sumiyoshi M, Hu YP, Koga K, Onitsuka M, Kojima D, Yue L, Takedatsu H, Jian YW, Inoue R.World J Gastroenterol.　21;24(35):4036-4053. , 2018
  7. Endoscopic analysis of colorectal serrated lesions with cancer.Nagata S, Mitsuyama K, Kawano H, Noda T, Maeyama Y, Mukasa M, Takedatsu H, Yoshioka S, Kuwaki K, Akiba J, Tsuruta O, Torimura T.Oncol Lett.　15(6):8655-8662.2018
  8. Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter studyIde T, Koga H, Nakano M, Hashimoto S, Yatsuhashi H, Higuchi N, Nakamuta M, Oeda S, Eguch Y, Shakado S, Sakisaka S, Yoshimaru Y, Sasaki Y, Honma Y, Harada M, Seike M, Maeshiro T, Miuma S, Nakao K, Mawatari S, Ido A, Nagata K, Matsumoto S, Takami Y,Sohda T,Tatsuyuki Kakuma T,Torimura THepatology International　https://doi.org/10.1007/s12072-019-09939-2
  9. 改訂自己免疫性肝炎・原発性胆汁性胆管炎診療ガイドライン田中篤、大平弘正、高橋敦史、小森敦正、阿部雅則、姜　貞憲、小池和彦、鈴木義之、高木章乃夫、有永照子、鳥村拓司、中本伸宏、原田憲一、十河剛、乾あやの、藤澤知雄、吉澤要、玄田拓哉、銭谷幹男、下田慎治、竹山康章、向坂彰太郎、谷合麻紀子、橋本悦子、中村稔、浪崎正、吉治仁志、本多彰、松崎靖司、廣原淳子、山際訓、滝川一肝臓　59(4),211-216,2018

症例報告

  1. Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.Takata K, Fukuda H, Umeda K, Yamauchi R, Fukuda S, Kunimoto H, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sakisaka S.Clin J Gastroenterol.　11(4):338-342,2018
  2. Autoimmune Hepatitis with Concomitant Idiopathic Thrombocytopenic Purpura Diagnosed by Transjungular Liver BiopsyFukuda H,Takata K,Kitaguchi T,Yamauchi R,Kunimoto H,Tanaka T,Yokoyama K,Morihara D,Takeyama Y,Shakado S,Mogi A,Kora S,Koga K,Takeshita M,Yoshimitsu K,Sakisaka SCase report in hepatology　doi.org/10.1155/2018/5305691
  3. Hepatic Pseudolymphoma with an Occult Hepatitis B Virus InfectionKunimoto H, Morihara D, Nakane S,Tanaka T, Yokoyama K, Anan A, Takeyama Y, Irie M, Shakado S, Noritomi T, Takeshita M,Yoshimitsu K, Sakisaka SInternal Medicine　57: 223-230, 2018
  4. Magnetic resonance cholangiopancreatography for afferent loop syndromeTakata K, Anan A, Umeda K, Sakisaka SClinical Case Reports　7:591-592,2019
  5. Hepatocellular carcinoma arising in a noncirrhotic liver with secondary hemochromatosis.Yamauchi R, Takata K, Shinagawa Y, Tanaka T, Fukuda H, Fukuda S, Kunimoto H, Umeda K, Morihara D, Yokoyama K, Takeyama Y, Irie M, Shakado S, Mizoguchi M, Hisano S, Yoshimitsu K and Sakisaka SInternal Medicine　58(5):661-665,2019
  6. 胃腎シャントが自然退縮した肝細胞癌門脈浸潤合併胃静脈瘤の１例山内　涼、横山圭二、福田祥、田中　崇、入江　真、向坂彰太郎日本門脈圧亢進症学会雑誌　24(2),154-160,2018
  7. 十二指腸下行脚に狭窄を来したmonomorphic epitheliotropic intestinal T-cell lymphomaの1例石橋英樹、二村　聡、萱嶋善行、久能宣昭、竹田津英稔、高松　泰、竹下盛重、向坂彰太郎胃と腸　53(12)1684-1692,2018

総説

  1. IL-5と消化管疾患阿部光市、竹田津英稔消化器病学サイエンス　2(4);39(203)-42(206),2018

著書

  1. 原発性硬化性胆管炎向坂彰太郎今日の治療指針　542-543,2018
  2. 炎症性メディエーター・サイトカインの関与竹田津英稔、光山慶一日本臨牀　炎症性腸疾患（第2版）　76巻増刊号3（通巻1140号）87-93,2018

福岡大学医学部 消化器内科 All Rights Reserved, 2019